Guardian Life Insurance’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,180
| Closed | -$383K | – | 422 |
|
|
2019
Q4 | $383K | Buy |
1,180
+8
| +0.7% | +$2.6K | 0.09% | 52 |
|
|
2019
Q3 | $341K | Buy |
1,172
+12
| +1% | +$3.49K | 0.05% | 68 |
|
|
2019
Q2 | $341K | Hold |
1,160
| – | – | 0.05% | 66 |
|
|
2019
Q1 | $318K | Buy |
1,160
+20
| +2% | +$5.48K | 0.04% | 74 |
|
|
2018
Q4 | $255K | Buy |
1,140
+4
| +0.4% | +$895 | 0.04% | 75 |
|
|
2018
Q3 | $277K | Buy |
1,136
+27
| +2% | +$6.58K | 0.05% | 78 |
|
|
2018
Q2 | $230K | Buy |
1,109
+187
| +20% | +$38.8K | 0.04% | 78 |
|
|
2018
Q1 | $190K | Sell |
922
-374
| -29% | -$77.1K | 0.04% | 79 |
|
|
2017
Q4 | $246K | Buy |
1,296
+387
| +43% | +$73.5K | 0.05% | 88 |
|
|
2017
Q3 | $172K | Buy |
909
+24
| +3% | +$4.54K | 0.03% | 85 |
|
|
2017
Q2 | $154K | Sell |
885
-624
| -41% | -$109K | 0.02% | 86 |
|
|
2017
Q1 | $232K | Sell |
1,509
-4
| -0.3% | -$615 | 0.03% | 99 |
|
|
2016
Q4 | $213K | Buy |
1,513
+36
| +2% | +$5.07K | 0.03% | 115 |
|
|
2016
Q3 | $235K | Hold |
1,477
| – | – | 0.02% | 131 |
|
|
2016
Q2 | $218K | Hold |
1,477
| – | – | 0.02% | 155 |
|
|
2016
Q1 | $209K | Sell |
1,477
-417
| -22% | -$59K | 0.02% | 155 |
|
|
2015
Q4 | $269K | Sell |
1,894
-436
| -19% | -$61.9K | 0.03% | 146 |
|
|
2015
Q3 | $285K | Buy |
2,330
+591
| +34% | +$72.3K | 0.03% | 156 |
|
|
2015
Q2 | $226K | Hold |
1,739
| – | – | 0.02% | 159 |
|
|
2015
Q1 | $234K | Sell |
1,739
-541
| -24% | -$72.8K | 0.02% | 165 |
|
|
2014
Q4 | $286K | Buy |
2,280
+11
| +0.5% | +$1.38K | 0.03% | 167 |
|
|
2014
Q3 | $276K | Buy |
2,269
+39
| +2% | +$4.74K | 0.03% | 165 |
|
|
2014
Q2 | $263K | Hold |
2,230
| – | – | 0.03% | 165 |
|
|
2014
Q1 | $268K | Buy |
2,230
+195
| +10% | +$23.4K | 0.02% | 166 |
|
|
2013
Q4 | $227K | Sell |
2,035
-2,269
| -53% | -$253K | 0.02% | 177 |
|
|
2013
Q3 | $397K | Hold |
4,304
| – | – | 0.03% | 192 |
|
|
2013
Q2 | $364K | Buy |
+4,304
| New | +$364K | 0.03% | 196 |
|